Industry reports
Editor highlights

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Ginger Oil AB (GIOI) - Financial and Strategic SWOT Analysis Review

Ginger Oil AB (GIOI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

Summary Ginger Oil AB (Ginger Oil) is an oil and natural gas exploration and development company, based in Sweden. It operates through the exploration, exploitation, development, extraction and production of oil and natural gas. Ginger Oil involved in exploration of new deposits and the expansion of ...

Industries: Drug and Medication | Countries: United States

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

Summary Lavipharm S.A (Lavipharm) is a an integrated company, which carries out developing, manufacturing, marketing and distribution of pharmaceutical, cosmetic, consumer health and over the counter (OTC) products. It provides various products for chronic pain, respiratory system, anti-inflammatory, ...

Industries: Drug and Medication | Countries: Greece, France, United States, Cyprus

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

Summary InforMedix Holdings, Inc. is engaged in the development, patenting and integrating of Med-eXpert system, an integrated Internet-based communication system that offers data analytics; and a database software platform to examine patient medication adherence and health status. Currently, the company ...

Industries: Drug and Medication | Countries: United States

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. American Bio Medica Corporation SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: United States

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: United States, India, World, Australia, South Africa, China

Psychemedics Corporation (Symbol:PMD) SWOT Analysis, Strategy, Revenues and Profits

Psychemedics Corporation (Symbol:PMD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Psychemedics Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States

Prometheus Laboratories Inc. SWOT Analysis, Strategy, Revenues and Profits

Prometheus Laboratories Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: United States

Anesthetic Conduction Catheters - Medical Device Safety and Approval Report - Comprehensive

Anesthetic Conduction Catheters - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • by DeviceMatters
  • April 2014
  • 58 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Anesthetic Conduction Catheters, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 745kb pdf report is ...

Industries: Drug and Medication | Countries: United States

Parathyroid Hormone Radioimmunoassays - Medical Device Safety and Approval Report - Comprehensive

Parathyroid Hormone Radioimmunoassays - Medical Device Safety and Approval Report - Comprehensive

  • $ 149
  • Industry report
  • by DeviceMatters
  • April 2014
  • 70 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Parathyroid Hormone Radioimmunoassays, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 798kb pdf report ...

Industries: Drug and Medication | Countries: United States

PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • by Global Data
  • March 2014
  • 143 pages

PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which ...

Industries: Drug and Medication | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.